BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6974040)

  • 1. Pancreatic carcinoma in azaserine-treated rats: induction, classification and dietary modulation of incidence.
    Longnecker DS; Roebuck BD; Yager JD; Lilja HS; Siegmund B
    Cancer; 1981 Mar; 47(6 Suppl):1562-72. PubMed ID: 6974040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent effects of retinoids on pancreatic and liver carcinogenesis in azaserine-treated rats.
    Longnecker DS; Kuhlmann ET; Curphey TJ
    Cancer Res; 1983 Jul; 43(7):3219-25. PubMed ID: 6601985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of pancreatic carcinogenesis by retinoids in azaserine-treated rats.
    Longnecker DS; Curphey TJ; Kuhlmann ET; Roebuck BD
    Cancer Res; 1982 Jan; 42(1):19-24. PubMed ID: 7053848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion by unsaturated fat of azaserine-induced pancreatic carcinogenesis in the rat.
    Roebuck BD; Yager JD; Longnecker DS; Wilpone SA
    Cancer Res; 1981 Oct; 41(10):3961-6. PubMed ID: 7285004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary modulation of azaserine-induced pancreatic carcinogenesis in the rat.
    Roebuck BD; Yager JD; Longnecker DS
    Cancer Res; 1981 Mar; 41(3):888-93. PubMed ID: 7459874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of corn oil and benzyl acetate on number and size of azaserine-induced foci in the pancreas of LEW and F344 rats.
    Longnecker DS; Roebuck BD; Curphey TJ; Lhoste E; Coon CI; MacMillan D
    Environ Health Perspect; 1986 Sep; 68():197-201. PubMed ID: 3490965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesions induced in rodent pancreas by azaserine and other pancreatic carcinogens.
    Longnecker DS
    Environ Health Perspect; 1984 Jun; 56():245-51. PubMed ID: 6332732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-azaserine induced preneoplasia in the rat pancreas. A morphometric study of dietary manipulation (lipotrope deficiency) and ultrastructural differentiation.
    Andry CD; Kupchik HZ; Rogers AE
    Toxicol Pathol; 1990; 18(1 Pt 1):10-7. PubMed ID: 2362985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azaserine-induced pancreatic carcinogenesis in rats: promotion by a diet rich in saturated fat and inhibition by a standard laboratory chow.
    Appel MJ; nan Garderen-Hoetmer A; Woutersen RA
    Cancer Lett; 1990 Dec; 55(3):239-48. PubMed ID: 2257542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic and biochemical effects of azaserine in inbred Wistar/Lewis rats and noninbred CD-1 mice.
    Roebuck BD; Lilja HS; Curphey TJ; Longnecker DS
    J Natl Cancer Inst; 1980 Aug; 65(2):383-9. PubMed ID: 6931255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dietary fats and soybean protein on azaserine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat.
    Roebuck BD; Kaplita PV; Edwards BR; Praissman M
    Cancer Res; 1987 Mar; 47(5):1333-8. PubMed ID: 3815341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-dose protocol for azaserine initiation of pancreatic carcinogenesis in the rat.
    Yager JD; Roebuck BD; Zurlo J; Longnecker DS; Weselcouch EO; Wilpone SA
    Int J Cancer; 1981 Nov; 28(5):601-6. PubMed ID: 6975760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of orchiectomy and testosterone on the early stages of azaserine-induced pancreatic carcinogenesis in the rat.
    Lhoste EF; Roebuck BD; Stern JE; Longnecker DS
    Pancreas; 1987; 2(1):38-43. PubMed ID: 3494994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of micronutrients on pancreatic carcinogenesis in azaserine-treated rats.
    Appel MJ; Roverts G; Woutersen RA
    Carcinogenesis; 1991 Nov; 12(11):2157-61. PubMed ID: 1934304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of azaserine-induced carcinomas of pancreas in rats.
    Longnecker DS; Lilja HS; French J; Kuhlmann E; Noll W
    Cancer Lett; 1979 Aug; 7(4):197-202. PubMed ID: 509403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305).
    Lhoste EF; Roebuck BD; Longnecker DS
    Carcinogenesis; 1988 Jun; 9(6):901-6. PubMed ID: 3259478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic carcinogenesis in azaserine-treated rats: inhibition by a solvent mixture in the diet.
    Longnecker DS; Kuhlmann ET; Roebuck BD; Curphey TJ
    Food Chem Toxicol; 1987 Nov; 25(11):823-8. PubMed ID: 3500902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of pancreatic acinar cell carcinoma by combined administration of 4-hydroxyaminoquinoline 1-oxide and azaserine in partial pancreatectomized rats.
    Konish Y; Denda A; Inui S; Takahashi S; Ueda N; Namiki M
    Cancer Lett; 1978 Apr; 4(4):229-34. PubMed ID: 417803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinoma of the pancreas in azaserine-treated rats.
    Longnecker DS; Curphey TJ
    Cancer Res; 1975 Aug; 35(8):2249-58. PubMed ID: 1097106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of pancreatic and liver carcinogenesis in rats by retinoid- and selenium-supplemented diets.
    Curphey TJ; Kuhlmann ET; Roebuck BD; Longnecker DS
    Pancreas; 1988; 3(1):36-40. PubMed ID: 3258990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.